Evaluation of Colorimetric Nitrate Reductase Assay in Liquid Medium for Detection of Resistance to First-line Antitubercular Drugs.

IF 1.6 Q4 INFECTIOUS DISEASES
International Journal of Mycobacteriology Pub Date : 2024-04-01 Epub Date: 2024-06-15 DOI:10.4103/ijmy.ijmy_69_24
Munaza Aman, Anjum Ara Mir, Gulnaz Bashir, Sayim Wani, Syed Khursheed, Irfan Nisar Ahangar
{"title":"Evaluation of Colorimetric Nitrate Reductase Assay in Liquid Medium for Detection of Resistance to First-line Antitubercular Drugs.","authors":"Munaza Aman, Anjum Ara Mir, Gulnaz Bashir, Sayim Wani, Syed Khursheed, Irfan Nisar Ahangar","doi":"10.4103/ijmy.ijmy_69_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>On a global scale, India holds the distinction of having the greatest number of tuberculosis (TB) cases caused by Mycobacterium tuberculosis (MTB) complex. The study aimed at evaluating the sensitivity, specificity, accuracy, cost, rapidity, and feasibility of the performance of the colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) test against the indirect proportion method (IPM) on Lowenstein-Jensen media as the gold standard.</p><p><strong>Methods: </strong>A comparative cross-sectional study was performed on 51 MTB isolates. Fresh subcultures were used for drug susceptibility testing by IPM on the Lowenstein-Jensen medium and the CONRAS method in liquid medium. Quality control for drug susceptibility testing was done using a known sensitive strain of MTB (H37Rv) and strains resistant to both isoniazid (INH) and rifampicin (RIF) - multidrug-resistant (MDR), mono-resistant to RIF, streptomycin (STM), and ethambutol (EMB). Statistical analysis was performed using MedCalc software (Version 20.027).</p><p><strong>Results: </strong>CONRAS, carried out in microfuge tubes, was cost-efficient and easy to perform/interpret with most results being available in 10 days compared to 42 days in the case of IPM. The sensitivity, specificity, and accuracy of RIF and INH were 100%, 97.37%, and 98.04 and 93.33%, 97.59%, and 96.08%, respectively, which translates into an almost perfect agreement between the two methods as indicated by κ value of 0.905 and 0.949, respectively, for the two drugs. The performance of CONRAS was less satisfactory for STM and EMB when compared to IPM.</p><p><strong>Conclusions: </strong>CONRAS may serve as a useful test for the detection of MDR-TB because of its accuracy, low cost, ease of performance/interpretation, and rapidity when compared to IPM on LJ medium. It does not involve the use of expensive reagents and equipment, as is the case with molecular methods like GeneXpert and line probe assay, making it a suitable option for the detection of MDR-TB in resource-poor settings.</p>","PeriodicalId":14133,"journal":{"name":"International Journal of Mycobacteriology","volume":"13 2","pages":"191-196"},"PeriodicalIF":1.6000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Mycobacteriology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijmy.ijmy_69_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: On a global scale, India holds the distinction of having the greatest number of tuberculosis (TB) cases caused by Mycobacterium tuberculosis (MTB) complex. The study aimed at evaluating the sensitivity, specificity, accuracy, cost, rapidity, and feasibility of the performance of the colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) test against the indirect proportion method (IPM) on Lowenstein-Jensen media as the gold standard.

Methods: A comparative cross-sectional study was performed on 51 MTB isolates. Fresh subcultures were used for drug susceptibility testing by IPM on the Lowenstein-Jensen medium and the CONRAS method in liquid medium. Quality control for drug susceptibility testing was done using a known sensitive strain of MTB (H37Rv) and strains resistant to both isoniazid (INH) and rifampicin (RIF) - multidrug-resistant (MDR), mono-resistant to RIF, streptomycin (STM), and ethambutol (EMB). Statistical analysis was performed using MedCalc software (Version 20.027).

Results: CONRAS, carried out in microfuge tubes, was cost-efficient and easy to perform/interpret with most results being available in 10 days compared to 42 days in the case of IPM. The sensitivity, specificity, and accuracy of RIF and INH were 100%, 97.37%, and 98.04 and 93.33%, 97.59%, and 96.08%, respectively, which translates into an almost perfect agreement between the two methods as indicated by κ value of 0.905 and 0.949, respectively, for the two drugs. The performance of CONRAS was less satisfactory for STM and EMB when compared to IPM.

Conclusions: CONRAS may serve as a useful test for the detection of MDR-TB because of its accuracy, low cost, ease of performance/interpretation, and rapidity when compared to IPM on LJ medium. It does not involve the use of expensive reagents and equipment, as is the case with molecular methods like GeneXpert and line probe assay, making it a suitable option for the detection of MDR-TB in resource-poor settings.

评估液体培养基中硝酸还原酶比色法检测一线抗结核药物耐药性的效果
背景:在全球范围内,印度是由结核分枝杆菌(MTB)复合体引起的结核病(TB)病例最多的国家。本研究旨在评估基于硝酸还原酶的比色法抗生素药敏试验(CONRAS)与作为金标准的洛文斯丹-詹森培养基间接比例法(IPM)的灵敏度、特异性、准确性、成本、快速性和可行性:方法:对 51 例 MTB 分离物进行了横断面比较研究。方法:对 51 株 MTB 分离物进行了横断面比较研究,使用新鲜亚培养物在 Lowenstein-Jensen 培养基上用 IPM 法和在液体培养基上用 CONRAS 法进行药敏试验。药敏试验的质量控制使用已知的 MTB 敏感菌株(H37Rv)和对异烟肼(INH)和利福平(RIF)均耐药的菌株--耐多药(MDR)、对 RIF、链霉素(STM)和乙胺丁醇(EMB)单耐药的菌株。统计分析使用 MedCalc 软件(20.027 版)进行:结果:在微量离心管中进行的 CONRAS 具有成本效益,且易于执行/解释,大多数结果可在 10 天内获得,而 IPM 则需要 42 天。RIF 和 INH 的灵敏度、特异性和准确性分别为 100%、97.37% 和 98.04%,以及 93.33%、97.59% 和 96.08%,这意味着两种方法几乎完全一致,两种药物的 κ 值分别为 0.905 和 0.949。与 IPM 相比,CONRAS 在 STM 和 EMB 方面的表现不尽如人意:与在 LJ 培养基上进行的 IPM 相比,CONRAS 具有准确、成本低、易于操作/解释和快速等优点,可作为检测 MDR-TB 的有用检测方法。与基因Xpert和线探针检测等分子方法相比,CONRAS不需要使用昂贵的试剂和设备,因此适合在资源匮乏的环境中检测耐药结核病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
25.00%
发文量
62
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信